nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Melatonin—CALR—esophageal cancer	0.0227	0.531	CrCbGaD
Zolmitriptan—Melatonin—CYP1B1—esophageal cancer	0.00495	0.116	CrCbGaD
Zolmitriptan—Eletriptan—CYP2A6—esophageal cancer	0.0044	0.103	CrCbGaD
Zolmitriptan—Melatonin—CYP19A1—esophageal cancer	0.00364	0.0851	CrCbGaD
Zolmitriptan—Eletriptan—PTGS1—esophageal cancer	0.00337	0.0789	CrCbGaD
Zolmitriptan—Dry eye—Capecitabine—esophageal cancer	0.00298	0.00468	CcSEcCtD
Zolmitriptan—Dehydration—Cisplatin—esophageal cancer	0.00296	0.00464	CcSEcCtD
Zolmitriptan—Oesophagitis—Capecitabine—esophageal cancer	0.00295	0.00463	CcSEcCtD
Zolmitriptan—Urine output increased—Capecitabine—esophageal cancer	0.00292	0.00458	CcSEcCtD
Zolmitriptan—Ecchymosis—Capecitabine—esophageal cancer	0.00292	0.00458	CcSEcCtD
Zolmitriptan—Neoplasm—Capecitabine—esophageal cancer	0.00292	0.00458	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Cisplatin—esophageal cancer	0.0029	0.00455	CcSEcCtD
Zolmitriptan—Apnoea—Methotrexate—esophageal cancer	0.00284	0.00445	CcSEcCtD
Zolmitriptan—Mental disability—Capecitabine—esophageal cancer	0.0028	0.00439	CcSEcCtD
Zolmitriptan—Speech disorder—Methotrexate—esophageal cancer	0.0028	0.00438	CcSEcCtD
Zolmitriptan—Ear pain—Capecitabine—esophageal cancer	0.00275	0.00431	CcSEcCtD
Zolmitriptan—Thrombophlebitis—Capecitabine—esophageal cancer	0.00271	0.00425	CcSEcCtD
Zolmitriptan—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.0027	0.00423	CcSEcCtD
Zolmitriptan—Pancreatitis—Cisplatin—esophageal cancer	0.00269	0.00423	CcSEcCtD
Zolmitriptan—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00268	0.0042	CcSEcCtD
Zolmitriptan—Photosensitivity—Capecitabine—esophageal cancer	0.00267	0.00419	CcSEcCtD
Zolmitriptan—Polyuria—Capecitabine—esophageal cancer	0.00267	0.00419	CcSEcCtD
Zolmitriptan—Gastroenteritis—Capecitabine—esophageal cancer	0.00264	0.00415	CcSEcCtD
Zolmitriptan—Eye pain—Capecitabine—esophageal cancer	0.0026	0.00407	CcSEcCtD
Zolmitriptan—Ulcer—Methotrexate—esophageal cancer	0.00254	0.00399	CcSEcCtD
Zolmitriptan—Amnesia—Capecitabine—esophageal cancer	0.0025	0.00391	CcSEcCtD
Zolmitriptan—Increased appetite—Capecitabine—esophageal cancer	0.0025	0.00391	CcSEcCtD
Zolmitriptan—Atrial fibrillation—Capecitabine—esophageal cancer	0.00247	0.00388	CcSEcCtD
Zolmitriptan—Thirst—Capecitabine—esophageal cancer	0.00246	0.00386	CcSEcCtD
Zolmitriptan—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00242	0.00379	CcSEcCtD
Zolmitriptan—Arthritis—Capecitabine—esophageal cancer	0.00241	0.00378	CcSEcCtD
Zolmitriptan—Vaginal inflammation—Methotrexate—esophageal cancer	0.0024	0.00377	CcSEcCtD
Zolmitriptan—Myocardial infarction—Cisplatin—esophageal cancer	0.0024	0.00377	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Cisplatin—esophageal cancer	0.0024	0.00377	CcSEcCtD
Zolmitriptan—Stomatitis—Cisplatin—esophageal cancer	0.00239	0.00375	CcSEcCtD
Zolmitriptan—Conjunctivitis—Cisplatin—esophageal cancer	0.00238	0.00374	CcSEcCtD
Zolmitriptan—Cystitis noninfective—Methotrexate—esophageal cancer	0.00235	0.00368	CcSEcCtD
Zolmitriptan—Melaena—Methotrexate—esophageal cancer	0.00235	0.00368	CcSEcCtD
Zolmitriptan—Diplopia—Capecitabine—esophageal cancer	0.00234	0.00368	CcSEcCtD
Zolmitriptan—Osteoarthritis—Capecitabine—esophageal cancer	0.00234	0.00368	CcSEcCtD
Zolmitriptan—Cystitis—Methotrexate—esophageal cancer	0.00232	0.00364	CcSEcCtD
Zolmitriptan—Migraine—Capecitabine—esophageal cancer	0.00231	0.00362	CcSEcCtD
Zolmitriptan—Vaginal infection—Methotrexate—esophageal cancer	0.00227	0.00356	CcSEcCtD
Zolmitriptan—Face oedema—Capecitabine—esophageal cancer	0.00226	0.00355	CcSEcCtD
Zolmitriptan—Bradycardia—Cisplatin—esophageal cancer	0.00224	0.00351	CcSEcCtD
Zolmitriptan—Irritability—Capecitabine—esophageal cancer	0.00224	0.00351	CcSEcCtD
Zolmitriptan—Mood swings—Capecitabine—esophageal cancer	0.00222	0.00348	CcSEcCtD
Zolmitriptan—Ataxia—Capecitabine—esophageal cancer	0.0022	0.00346	CcSEcCtD
Zolmitriptan—Dehydration—Capecitabine—esophageal cancer	0.00218	0.00342	CcSEcCtD
Zolmitriptan—Bladder pain—Methotrexate—esophageal cancer	0.00217	0.00341	CcSEcCtD
Zolmitriptan—Neoplasm—Methotrexate—esophageal cancer	0.00217	0.00341	CcSEcCtD
Zolmitriptan—Ecchymosis—Methotrexate—esophageal cancer	0.00217	0.00341	CcSEcCtD
Zolmitriptan—Urine output increased—Methotrexate—esophageal cancer	0.00217	0.00341	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Cisplatin—esophageal cancer	0.00217	0.00341	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Cisplatin—esophageal cancer	0.00216	0.00339	CcSEcCtD
Zolmitriptan—Urethral disorder—Cisplatin—esophageal cancer	0.00216	0.00338	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00214	0.00336	CcSEcCtD
Zolmitriptan—Pulmonary oedema—Methotrexate—esophageal cancer	0.00214	0.00336	CcSEcCtD
Zolmitriptan—Gastritis—Capecitabine—esophageal cancer	0.00207	0.00325	CcSEcCtD
Zolmitriptan—Muscular weakness—Capecitabine—esophageal cancer	0.00207	0.00324	CcSEcCtD
Zolmitriptan—Tinnitus—Cisplatin—esophageal cancer	0.00205	0.00322	CcSEcCtD
Zolmitriptan—Lymphadenopathy—Methotrexate—esophageal cancer	0.00205	0.00321	CcSEcCtD
Zolmitriptan—Cardiac disorder—Cisplatin—esophageal cancer	0.00204	0.0032	CcSEcCtD
Zolmitriptan—Dysphagia—Capecitabine—esophageal cancer	0.00203	0.00318	CcSEcCtD
Zolmitriptan—Influenza—Capecitabine—esophageal cancer	0.00203	0.00318	CcSEcCtD
Zolmitriptan—Sumatriptan—ABCB1—esophageal cancer	0.00203	0.0474	CrCbGaD
Zolmitriptan—Thrombophlebitis—Methotrexate—esophageal cancer	0.00202	0.00316	CcSEcCtD
Zolmitriptan—Bronchospasm—Capecitabine—esophageal cancer	0.00199	0.00312	CcSEcCtD
Zolmitriptan—Photosensitivity—Methotrexate—esophageal cancer	0.00199	0.00312	CcSEcCtD
Zolmitriptan—Polyuria—Methotrexate—esophageal cancer	0.00199	0.00312	CcSEcCtD
Zolmitriptan—Immune system disorder—Cisplatin—esophageal cancer	0.00199	0.00312	CcSEcCtD
Zolmitriptan—Angina pectoris—Capecitabine—esophageal cancer	0.00197	0.00309	CcSEcCtD
Zolmitriptan—Arrhythmia—Cisplatin—esophageal cancer	0.00197	0.00308	CcSEcCtD
Zolmitriptan—Bronchitis—Capecitabine—esophageal cancer	0.00195	0.00306	CcSEcCtD
Zolmitriptan—Erythema—Cisplatin—esophageal cancer	0.00192	0.003	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00185	0.0029	CcSEcCtD
Zolmitriptan—Weight increased—Capecitabine—esophageal cancer	0.00184	0.00289	CcSEcCtD
Zolmitriptan—Muscle spasms—Cisplatin—esophageal cancer	0.00184	0.00289	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Capecitabine—esophageal cancer	0.00183	0.00287	CcSEcCtD
Zolmitriptan—Pneumonia—Capecitabine—esophageal cancer	0.00182	0.00285	CcSEcCtD
Zolmitriptan—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.0018	0.00283	CcSEcCtD
Zolmitriptan—Tremor—Cisplatin—esophageal cancer	0.00179	0.00281	CcSEcCtD
Zolmitriptan—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00178	0.00279	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Cisplatin—esophageal cancer	0.00178	0.00279	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00177	0.00278	CcSEcCtD
Zolmitriptan—Myocardial infarction—Capecitabine—esophageal cancer	0.00177	0.00278	CcSEcCtD
Zolmitriptan—Stomatitis—Capecitabine—esophageal cancer	0.00176	0.00276	CcSEcCtD
Zolmitriptan—Jaundice—Capecitabine—esophageal cancer	0.00176	0.00276	CcSEcCtD
Zolmitriptan—Urinary tract infection—Capecitabine—esophageal cancer	0.00176	0.00275	CcSEcCtD
Zolmitriptan—Conjunctivitis—Capecitabine—esophageal cancer	0.00176	0.00275	CcSEcCtD
Zolmitriptan—Osteoarthritis—Methotrexate—esophageal cancer	0.00175	0.00274	CcSEcCtD
Zolmitriptan—Malaise—Cisplatin—esophageal cancer	0.00173	0.00271	CcSEcCtD
Zolmitriptan—Haematuria—Capecitabine—esophageal cancer	0.00172	0.0027	CcSEcCtD
Zolmitriptan—Leukopenia—Cisplatin—esophageal cancer	0.00171	0.00269	CcSEcCtD
Zolmitriptan—Epistaxis—Capecitabine—esophageal cancer	0.0017	0.00267	CcSEcCtD
Zolmitriptan—Irritability—Methotrexate—esophageal cancer	0.00167	0.00261	CcSEcCtD
Zolmitriptan—Convulsion—Cisplatin—esophageal cancer	0.00166	0.0026	CcSEcCtD
Zolmitriptan—Mood swings—Methotrexate—esophageal cancer	0.00165	0.00259	CcSEcCtD
Zolmitriptan—Bradycardia—Capecitabine—esophageal cancer	0.00165	0.00259	CcSEcCtD
Zolmitriptan—Ataxia—Methotrexate—esophageal cancer	0.00164	0.00257	CcSEcCtD
Zolmitriptan—Eletriptan—ABCB1—esophageal cancer	0.00164	0.0384	CrCbGaD
Zolmitriptan—Myalgia—Cisplatin—esophageal cancer	0.00163	0.00256	CcSEcCtD
Zolmitriptan—Rhinitis—Capecitabine—esophageal cancer	0.00163	0.00255	CcSEcCtD
Zolmitriptan—Anxiety—Cisplatin—esophageal cancer	0.00162	0.00255	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Capecitabine—esophageal cancer	0.00161	0.00253	CcSEcCtD
Zolmitriptan—Discomfort—Cisplatin—esophageal cancer	0.00161	0.00253	CcSEcCtD
Zolmitriptan—Pharyngitis—Capecitabine—esophageal cancer	0.00161	0.00252	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Capecitabine—esophageal cancer	0.0016	0.00251	CcSEcCtD
Zolmitriptan—Oedema peripheral—Capecitabine—esophageal cancer	0.0016	0.00251	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Capecitabine—esophageal cancer	0.00159	0.0025	CcSEcCtD
Zolmitriptan—Urethral disorder—Capecitabine—esophageal cancer	0.00159	0.00249	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Cisplatin—esophageal cancer	0.00156	0.00245	CcSEcCtD
Zolmitriptan—Oedema—Cisplatin—esophageal cancer	0.00156	0.00245	CcSEcCtD
Zolmitriptan—Infection—Cisplatin—esophageal cancer	0.00155	0.00243	CcSEcCtD
Zolmitriptan—Nervous system disorder—Cisplatin—esophageal cancer	0.00153	0.0024	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Cisplatin—esophageal cancer	0.00153	0.0024	CcSEcCtD
Zolmitriptan—Tachycardia—Cisplatin—esophageal cancer	0.00153	0.00239	CcSEcCtD
Zolmitriptan—Skin disorder—Cisplatin—esophageal cancer	0.00152	0.00238	CcSEcCtD
Zolmitriptan—Tinnitus—Capecitabine—esophageal cancer	0.00151	0.00237	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Cisplatin—esophageal cancer	0.00151	0.00237	CcSEcCtD
Zolmitriptan—Cardiac disorder—Capecitabine—esophageal cancer	0.00151	0.00236	CcSEcCtD
Zolmitriptan—Eosinophilia—Methotrexate—esophageal cancer	0.00149	0.00234	CcSEcCtD
Zolmitriptan—Anorexia—Cisplatin—esophageal cancer	0.00149	0.00234	CcSEcCtD
Zolmitriptan—Pancreatitis—Methotrexate—esophageal cancer	0.00148	0.00232	CcSEcCtD
Zolmitriptan—Angiopathy—Capecitabine—esophageal cancer	0.00147	0.00231	CcSEcCtD
Zolmitriptan—Immune system disorder—Capecitabine—esophageal cancer	0.00146	0.0023	CcSEcCtD
Zolmitriptan—Chills—Capecitabine—esophageal cancer	0.00146	0.00228	CcSEcCtD
Zolmitriptan—Arrhythmia—Capecitabine—esophageal cancer	0.00145	0.00227	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00142	0.00223	CcSEcCtD
Zolmitriptan—Erythema—Capecitabine—esophageal cancer	0.00141	0.00221	CcSEcCtD
Zolmitriptan—Paraesthesia—Cisplatin—esophageal cancer	0.0014	0.0022	CcSEcCtD
Zolmitriptan—Dyspnoea—Cisplatin—esophageal cancer	0.00139	0.00219	CcSEcCtD
Zolmitriptan—Dysgeusia—Capecitabine—esophageal cancer	0.00138	0.00217	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00138	0.00216	CcSEcCtD
Zolmitriptan—Back pain—Capecitabine—esophageal cancer	0.00137	0.00214	CcSEcCtD
Zolmitriptan—Decreased appetite—Cisplatin—esophageal cancer	0.00136	0.00213	CcSEcCtD
Zolmitriptan—Muscle spasms—Capecitabine—esophageal cancer	0.00136	0.00213	CcSEcCtD
Zolmitriptan—Pneumonia—Methotrexate—esophageal cancer	0.00135	0.00212	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00135	0.00212	CcSEcCtD
Zolmitriptan—Pain—Cisplatin—esophageal cancer	0.00134	0.0021	CcSEcCtD
Zolmitriptan—Tremor—Capecitabine—esophageal cancer	0.00132	0.00207	CcSEcCtD
Zolmitriptan—Stomatitis—Methotrexate—esophageal cancer	0.00131	0.00206	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Capecitabine—esophageal cancer	0.00131	0.00205	CcSEcCtD
Zolmitriptan—Conjunctivitis—Methotrexate—esophageal cancer	0.00131	0.00205	CcSEcCtD
Zolmitriptan—Sweating—Methotrexate—esophageal cancer	0.00129	0.00202	CcSEcCtD
Zolmitriptan—Feeling abnormal—Cisplatin—esophageal cancer	0.00129	0.00202	CcSEcCtD
Zolmitriptan—Haematuria—Methotrexate—esophageal cancer	0.00128	0.00201	CcSEcCtD
Zolmitriptan—Malaise—Capecitabine—esophageal cancer	0.00127	0.002	CcSEcCtD
Zolmitriptan—Epistaxis—Methotrexate—esophageal cancer	0.00127	0.00199	CcSEcCtD
Zolmitriptan—Vertigo—Capecitabine—esophageal cancer	0.00127	0.00199	CcSEcCtD
Zolmitriptan—Syncope—Capecitabine—esophageal cancer	0.00127	0.00199	CcSEcCtD
Zolmitriptan—Leukopenia—Capecitabine—esophageal cancer	0.00126	0.00198	CcSEcCtD
Zolmitriptan—Palpitations—Capecitabine—esophageal cancer	0.00125	0.00196	CcSEcCtD
Zolmitriptan—Loss of consciousness—Capecitabine—esophageal cancer	0.00124	0.00195	CcSEcCtD
Zolmitriptan—Body temperature increased—Cisplatin—esophageal cancer	0.00124	0.00194	CcSEcCtD
Zolmitriptan—Cough—Capecitabine—esophageal cancer	0.00123	0.00193	CcSEcCtD
Zolmitriptan—Hypertension—Capecitabine—esophageal cancer	0.00122	0.00191	CcSEcCtD
Zolmitriptan—Arthralgia—Capecitabine—esophageal cancer	0.0012	0.00188	CcSEcCtD
Zolmitriptan—Chest pain—Capecitabine—esophageal cancer	0.0012	0.00188	CcSEcCtD
Zolmitriptan—Myalgia—Capecitabine—esophageal cancer	0.0012	0.00188	CcSEcCtD
Zolmitriptan—Pharyngitis—Methotrexate—esophageal cancer	0.0012	0.00188	CcSEcCtD
Zolmitriptan—Anxiety—Capecitabine—esophageal cancer	0.0012	0.00188	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Methotrexate—esophageal cancer	0.00119	0.00187	CcSEcCtD
Zolmitriptan—Discomfort—Capecitabine—esophageal cancer	0.00119	0.00186	CcSEcCtD
Zolmitriptan—Urethral disorder—Methotrexate—esophageal cancer	0.00118	0.00186	CcSEcCtD
Zolmitriptan—Dry mouth—Capecitabine—esophageal cancer	0.00118	0.00184	CcSEcCtD
Zolmitriptan—Confusional state—Capecitabine—esophageal cancer	0.00116	0.00182	CcSEcCtD
Zolmitriptan—Oedema—Capecitabine—esophageal cancer	0.00115	0.00181	CcSEcCtD
Zolmitriptan—Hypersensitivity—Cisplatin—esophageal cancer	0.00115	0.00181	CcSEcCtD
Zolmitriptan—Infection—Capecitabine—esophageal cancer	0.00114	0.00179	CcSEcCtD
Zolmitriptan—Shock—Capecitabine—esophageal cancer	0.00113	0.00178	CcSEcCtD
Zolmitriptan—Nervous system disorder—Capecitabine—esophageal cancer	0.00113	0.00177	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Capecitabine—esophageal cancer	0.00113	0.00177	CcSEcCtD
Zolmitriptan—Tinnitus—Methotrexate—esophageal cancer	0.00113	0.00176	CcSEcCtD
Zolmitriptan—Tachycardia—Capecitabine—esophageal cancer	0.00112	0.00176	CcSEcCtD
Zolmitriptan—Asthenia—Cisplatin—esophageal cancer	0.00112	0.00176	CcSEcCtD
Zolmitriptan—Cardiac disorder—Methotrexate—esophageal cancer	0.00112	0.00176	CcSEcCtD
Zolmitriptan—Skin disorder—Capecitabine—esophageal cancer	0.00112	0.00175	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Capecitabine—esophageal cancer	0.00111	0.00175	CcSEcCtD
Zolmitriptan—Anorexia—Capecitabine—esophageal cancer	0.0011	0.00172	CcSEcCtD
Zolmitriptan—Angiopathy—Methotrexate—esophageal cancer	0.0011	0.00172	CcSEcCtD
Zolmitriptan—Immune system disorder—Methotrexate—esophageal cancer	0.00109	0.00171	CcSEcCtD
Zolmitriptan—Chills—Methotrexate—esophageal cancer	0.00108	0.0017	CcSEcCtD
Zolmitriptan—Diarrhoea—Cisplatin—esophageal cancer	0.00107	0.00168	CcSEcCtD
Zolmitriptan—Erythema—Methotrexate—esophageal cancer	0.00105	0.00165	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00105	0.00165	CcSEcCtD
Zolmitriptan—Insomnia—Capecitabine—esophageal cancer	0.00104	0.00163	CcSEcCtD
Zolmitriptan—Paraesthesia—Capecitabine—esophageal cancer	0.00103	0.00162	CcSEcCtD
Zolmitriptan—Dysgeusia—Methotrexate—esophageal cancer	0.00103	0.00161	CcSEcCtD
Zolmitriptan—Dyspnoea—Capecitabine—esophageal cancer	0.00103	0.00161	CcSEcCtD
Zolmitriptan—Back pain—Methotrexate—esophageal cancer	0.00102	0.00159	CcSEcCtD
Zolmitriptan—Dyspepsia—Capecitabine—esophageal cancer	0.00101	0.00159	CcSEcCtD
Zolmitriptan—Decreased appetite—Capecitabine—esophageal cancer	0.001	0.00157	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000995	0.00156	CcSEcCtD
Zolmitriptan—Vomiting—Cisplatin—esophageal cancer	0.000994	0.00156	CcSEcCtD
Zolmitriptan—Rash—Cisplatin—esophageal cancer	0.000986	0.00155	CcSEcCtD
Zolmitriptan—Constipation—Capecitabine—esophageal cancer	0.000985	0.00154	CcSEcCtD
Zolmitriptan—Pain—Capecitabine—esophageal cancer	0.000985	0.00154	CcSEcCtD
Zolmitriptan—Dermatitis—Cisplatin—esophageal cancer	0.000985	0.00154	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Methotrexate—esophageal cancer	0.000975	0.00153	CcSEcCtD
Zolmitriptan—Feeling abnormal—Capecitabine—esophageal cancer	0.000949	0.00149	CcSEcCtD
Zolmitriptan—Malaise—Methotrexate—esophageal cancer	0.000948	0.00149	CcSEcCtD
Zolmitriptan—Vertigo—Methotrexate—esophageal cancer	0.000944	0.00148	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000942	0.00148	CcSEcCtD
Zolmitriptan—Leukopenia—Methotrexate—esophageal cancer	0.000941	0.00148	CcSEcCtD
Zolmitriptan—Nausea—Cisplatin—esophageal cancer	0.000928	0.00146	CcSEcCtD
Zolmitriptan—Cough—Methotrexate—esophageal cancer	0.000917	0.00144	CcSEcCtD
Zolmitriptan—Urticaria—Capecitabine—esophageal cancer	0.000915	0.00144	CcSEcCtD
Zolmitriptan—Abdominal pain—Capecitabine—esophageal cancer	0.000911	0.00143	CcSEcCtD
Zolmitriptan—Body temperature increased—Capecitabine—esophageal cancer	0.000911	0.00143	CcSEcCtD
Zolmitriptan—Convulsion—Methotrexate—esophageal cancer	0.000911	0.00143	CcSEcCtD
Zolmitriptan—Arthralgia—Methotrexate—esophageal cancer	0.000895	0.0014	CcSEcCtD
Zolmitriptan—Chest pain—Methotrexate—esophageal cancer	0.000895	0.0014	CcSEcCtD
Zolmitriptan—Myalgia—Methotrexate—esophageal cancer	0.000895	0.0014	CcSEcCtD
Zolmitriptan—Discomfort—Methotrexate—esophageal cancer	0.000884	0.00139	CcSEcCtD
Zolmitriptan—Confusional state—Methotrexate—esophageal cancer	0.000865	0.00136	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Methotrexate—esophageal cancer	0.000858	0.00134	CcSEcCtD
Zolmitriptan—Infection—Methotrexate—esophageal cancer	0.000852	0.00134	CcSEcCtD
Zolmitriptan—Hypersensitivity—Capecitabine—esophageal cancer	0.000849	0.00133	CcSEcCtD
Zolmitriptan—Nervous system disorder—Methotrexate—esophageal cancer	0.000841	0.00132	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Methotrexate—esophageal cancer	0.00084	0.00132	CcSEcCtD
Zolmitriptan—Skin disorder—Methotrexate—esophageal cancer	0.000833	0.00131	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Methotrexate—esophageal cancer	0.000829	0.0013	CcSEcCtD
Zolmitriptan—Asthenia—Capecitabine—esophageal cancer	0.000827	0.0013	CcSEcCtD
Zolmitriptan—Anorexia—Methotrexate—esophageal cancer	0.000818	0.00128	CcSEcCtD
Zolmitriptan—Pruritus—Capecitabine—esophageal cancer	0.000815	0.00128	CcSEcCtD
Zolmitriptan—Diarrhoea—Capecitabine—esophageal cancer	0.000788	0.00124	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000781	0.00123	CcSEcCtD
Zolmitriptan—Insomnia—Methotrexate—esophageal cancer	0.000776	0.00122	CcSEcCtD
Zolmitriptan—Paraesthesia—Methotrexate—esophageal cancer	0.00077	0.00121	CcSEcCtD
Zolmitriptan—Dyspnoea—Methotrexate—esophageal cancer	0.000765	0.0012	CcSEcCtD
Zolmitriptan—Somnolence—Methotrexate—esophageal cancer	0.000763	0.0012	CcSEcCtD
Zolmitriptan—Dizziness—Capecitabine—esophageal cancer	0.000762	0.00119	CcSEcCtD
Zolmitriptan—Dyspepsia—Methotrexate—esophageal cancer	0.000755	0.00118	CcSEcCtD
Zolmitriptan—Decreased appetite—Methotrexate—esophageal cancer	0.000746	0.00117	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000741	0.00116	CcSEcCtD
Zolmitriptan—Pain—Methotrexate—esophageal cancer	0.000733	0.00115	CcSEcCtD
Zolmitriptan—Vomiting—Capecitabine—esophageal cancer	0.000733	0.00115	CcSEcCtD
Zolmitriptan—Rash—Capecitabine—esophageal cancer	0.000726	0.00114	CcSEcCtD
Zolmitriptan—Dermatitis—Capecitabine—esophageal cancer	0.000726	0.00114	CcSEcCtD
Zolmitriptan—Headache—Capecitabine—esophageal cancer	0.000722	0.00113	CcSEcCtD
Zolmitriptan—Feeling abnormal—Methotrexate—esophageal cancer	0.000707	0.00111	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000701	0.0011	CcSEcCtD
Zolmitriptan—Nausea—Capecitabine—esophageal cancer	0.000684	0.00107	CcSEcCtD
Zolmitriptan—Urticaria—Methotrexate—esophageal cancer	0.000681	0.00107	CcSEcCtD
Zolmitriptan—Body temperature increased—Methotrexate—esophageal cancer	0.000678	0.00106	CcSEcCtD
Zolmitriptan—Abdominal pain—Methotrexate—esophageal cancer	0.000678	0.00106	CcSEcCtD
Zolmitriptan—Hypersensitivity—Methotrexate—esophageal cancer	0.000632	0.000991	CcSEcCtD
Zolmitriptan—Asthenia—Methotrexate—esophageal cancer	0.000615	0.000965	CcSEcCtD
Zolmitriptan—Pruritus—Methotrexate—esophageal cancer	0.000607	0.000952	CcSEcCtD
Zolmitriptan—Diarrhoea—Methotrexate—esophageal cancer	0.000587	0.00092	CcSEcCtD
Zolmitriptan—Dizziness—Methotrexate—esophageal cancer	0.000567	0.000889	CcSEcCtD
Zolmitriptan—Vomiting—Methotrexate—esophageal cancer	0.000545	0.000855	CcSEcCtD
Zolmitriptan—Rash—Methotrexate—esophageal cancer	0.000541	0.000848	CcSEcCtD
Zolmitriptan—Dermatitis—Methotrexate—esophageal cancer	0.00054	0.000847	CcSEcCtD
Zolmitriptan—Headache—Methotrexate—esophageal cancer	0.000537	0.000843	CcSEcCtD
Zolmitriptan—Nausea—Methotrexate—esophageal cancer	0.000509	0.000799	CcSEcCtD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000315	0.000985	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GNG7—esophageal cancer	0.00031	0.000972	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FKBP1A—esophageal cancer	0.000308	0.000964	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000308	0.000963	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—ANXA1—esophageal cancer	0.000303	0.000949	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FKBP1A—esophageal cancer	0.000302	0.000944	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—WIF1—esophageal cancer	0.000301	0.000943	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.0003	0.000939	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000299	0.000937	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000298	0.000933	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—ANXA1—esophageal cancer	0.000297	0.000929	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KMT2D—esophageal cancer	0.000296	0.000928	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL2—esophageal cancer	0.000296	0.000927	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000296	0.000926	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—SST—esophageal cancer	0.000295	0.000923	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—WIF1—esophageal cancer	0.000295	0.000923	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000293	0.000917	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000293	0.000917	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—XIAP—esophageal cancer	0.000291	0.000911	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PDE4D—esophageal cancer	0.00029	0.000908	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL2—esophageal cancer	0.00029	0.000908	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—SST—esophageal cancer	0.000289	0.000904	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKAP13—esophageal cancer	0.000288	0.000902	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GHRL—esophageal cancer	0.000287	0.000899	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GHRL—esophageal cancer	0.000281	0.000881	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CSNK1A1—esophageal cancer	0.000278	0.00087	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ADH1B—esophageal cancer	0.000277	0.000867	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GNG7—esophageal cancer	0.000276	0.000864	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—ANXA1—esophageal cancer	0.000275	0.000862	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CTNNA1—esophageal cancer	0.000275	0.000861	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL2—esophageal cancer	0.000274	0.000856	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CSNK1A1—esophageal cancer	0.000272	0.000852	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—ANXA1—esophageal cancer	0.00027	0.000844	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—SST—esophageal cancer	0.000268	0.000838	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TYMP—esophageal cancer	0.000265	0.000829	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADCYAP1—esophageal cancer	0.000264	0.000827	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PDE4D—esophageal cancer	0.000264	0.000825	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—SST—esophageal cancer	0.000262	0.000821	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GHRL—esophageal cancer	0.000261	0.000817	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PFN1—esophageal cancer	0.00026	0.000814	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP26A1—esophageal cancer	0.000258	0.000806	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GHRL—esophageal cancer	0.000256	0.0008	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PSME1—esophageal cancer	0.000256	0.0008	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PSME2—esophageal cancer	0.000256	0.0008	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PFN1—esophageal cancer	0.000255	0.000797	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ANXA1—esophageal cancer	0.000254	0.000796	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALOX15—esophageal cancer	0.000251	0.000786	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GNG7—esophageal cancer	0.000251	0.000785	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SST—esophageal cancer	0.000247	0.000774	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000243	0.000761	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—WWOX—esophageal cancer	0.000242	0.000756	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOTCH3—esophageal cancer	0.000241	0.000755	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GHRL—esophageal cancer	0.000241	0.000755	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTO1—esophageal cancer	0.00024	0.00075	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TPI1—esophageal cancer	0.00024	0.00075	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—FBXW7—esophageal cancer	0.000237	0.000742	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ELMO1—esophageal cancer	0.000234	0.000731	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FKBP1A—esophageal cancer	0.00023	0.000719	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALDOB—esophageal cancer	0.00023	0.000719	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ELMO1—esophageal cancer	0.000229	0.000716	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKAP13—esophageal cancer	0.000228	0.000714	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000226	0.000708	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—WIF1—esophageal cancer	0.000225	0.000703	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKAP13—esophageal cancer	0.000223	0.000699	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GAPDH—esophageal cancer	0.000221	0.000692	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL2—esophageal cancer	0.000221	0.000691	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—SST—esophageal cancer	0.00022	0.000688	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CRABP1—esophageal cancer	0.000219	0.000686	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOTCH2—esophageal cancer	0.000216	0.000677	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GHRL—esophageal cancer	0.000214	0.000671	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000211	0.000659	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PDE4D—esophageal cancer	0.000209	0.000653	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GNG7—esophageal cancer	0.000208	0.000652	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000208	0.000651	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000207	0.000649	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000206	0.000646	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ANXA1—esophageal cancer	0.000205	0.000643	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PDE4D—esophageal cancer	0.000204	0.00064	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—SST—esophageal cancer	0.0002	0.000625	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GNG7—esophageal cancer	0.000199	0.000621	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALDH2—esophageal cancer	0.000195	0.000611	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GHRL—esophageal cancer	0.000195	0.000609	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GNG7—esophageal cancer	0.000194	0.000608	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PFN1—esophageal cancer	0.000194	0.000607	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFBR2—esophageal cancer	0.000192	0.0006	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—XIAP—esophageal cancer	0.000186	0.000582	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTT1—esophageal cancer	0.000186	0.000581	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP2A6—esophageal cancer	0.000184	0.000575	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—XIAP—esophageal cancer	0.000182	0.00057	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SMAD4—esophageal cancer	0.000182	0.000568	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000181	0.000568	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CTNNA1—esophageal cancer	0.000176	0.000551	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL2—esophageal cancer	0.000175	0.000548	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ELMO1—esophageal cancer	0.000174	0.000545	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS1—esophageal cancer	0.000174	0.000545	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ENO1—esophageal cancer	0.000174	0.000545	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CTNNA1—esophageal cancer	0.000172	0.000539	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PSME2—esophageal cancer	0.000171	0.000537	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PSME1—esophageal cancer	0.000171	0.000537	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL2—esophageal cancer	0.000171	0.000536	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKAP13—esophageal cancer	0.00017	0.000533	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PSME1—esophageal cancer	0.000163	0.000511	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PSME2—esophageal cancer	0.000163	0.000511	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ANXA1—esophageal cancer	0.000163	0.000509	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000161	0.000505	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000161	0.000505	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PSME2—esophageal cancer	0.00016	0.000501	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PSME1—esophageal cancer	0.00016	0.000501	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ANXA1—esophageal cancer	0.000159	0.000498	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SST—esophageal cancer	0.000158	0.000495	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000157	0.000492	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDE4D—esophageal cancer	0.000156	0.000487	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SST—esophageal cancer	0.000155	0.000485	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH3—esophageal cancer	0.000154	0.000483	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GHRL—esophageal cancer	0.000154	0.000483	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FBXW7—esophageal cancer	0.000152	0.000475	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH3—esophageal cancer	0.000151	0.000472	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GHRL—esophageal cancer	0.000151	0.000472	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HIF1A—esophageal cancer	0.000149	0.000465	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FBXW7—esophageal cancer	0.000149	0.000465	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNG7—esophageal cancer	0.000148	0.000464	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP1B1—esophageal cancer	0.000148	0.000463	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000144	0.000451	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KDR—esophageal cancer	0.000142	0.000445	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP19A1—esophageal cancer	0.000139	0.000435	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—XIAP—esophageal cancer	0.000139	0.000434	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH2—esophageal cancer	0.000138	0.000433	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CA1—esophageal cancer	0.000137	0.000429	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000137	0.000429	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000135	0.000424	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOTCH1—esophageal cancer	0.000134	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CTNNA1—esophageal cancer	0.000131	0.000411	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL2—esophageal cancer	0.00013	0.000408	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—HMOX1—esophageal cancer	0.000127	0.000397	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CA2—esophageal cancer	0.000125	0.000392	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFBR2—esophageal cancer	0.000123	0.000384	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000123	0.000384	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSME1—esophageal cancer	0.000122	0.000381	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSME2—esophageal cancer	0.000122	0.000381	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ABCB1—esophageal cancer	0.000122	0.000381	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CREBBP—esophageal cancer	0.000121	0.00038	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ANXA1—esophageal cancer	0.000121	0.00038	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFBR2—esophageal cancer	0.00012	0.000376	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—EGFR—esophageal cancer	0.000119	0.000373	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SST—esophageal cancer	0.000118	0.000369	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000117	0.000365	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000117	0.000365	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SMAD4—esophageal cancer	0.000116	0.000363	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000115	0.000361	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000115	0.00036	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GHRL—esophageal cancer	0.000115	0.00036	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000114	0.000357	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SMAD4—esophageal cancer	0.000114	0.000356	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FBXW7—esophageal cancer	0.000113	0.000354	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOS3—esophageal cancer	0.000109	0.00034	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PIK3CA—esophageal cancer	0.000104	0.000324	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000103	0.000323	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000102	0.00032	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ERBB2—esophageal cancer	0.000102	0.000318	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TYMP—esophageal cancer	9.77e-05	0.000306	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP26A1—esophageal cancer	9.5e-05	0.000297	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HIF1A—esophageal cancer	9.5e-05	0.000297	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIF1A—esophageal cancer	9.3e-05	0.000291	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALOX15—esophageal cancer	9.26e-05	0.00029	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFBR2—esophageal cancer	9.15e-05	0.000286	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—esophageal cancer	9.09e-05	0.000284	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCND1—esophageal cancer	8.98e-05	0.000281	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—esophageal cancer	8.9e-05	0.000278	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TPI1—esophageal cancer	8.83e-05	0.000276	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTO1—esophageal cancer	8.83e-05	0.000276	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1A—esophageal cancer	8.69e-05	0.000272	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SMAD4—esophageal cancer	8.66e-05	0.000271	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH1—esophageal cancer	8.56e-05	0.000268	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDOB—esophageal cancer	8.47e-05	0.000265	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH1—esophageal cancer	8.38e-05	0.000262	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EP300—esophageal cancer	8.27e-05	0.000259	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GAPDH—esophageal cancer	8.15e-05	0.000255	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CREBBP—esophageal cancer	8.14e-05	0.000255	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CRABP1—esophageal cancer	8.08e-05	0.000253	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CREBBP—esophageal cancer	7.76e-05	0.000243	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNG7—esophageal cancer	7.68e-05	0.000241	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—esophageal cancer	7.63e-05	0.000239	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CREBBP—esophageal cancer	7.6e-05	0.000238	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—esophageal cancer	7.47e-05	0.000234	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NOS3—esophageal cancer	7.29e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—esophageal cancer	7.29e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—esophageal cancer	7.2e-05	0.000225	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDH2—esophageal cancer	7.2e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	7.14e-05	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	7.09e-05	0.000222	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—esophageal cancer	7.04e-05	0.00022	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOS3—esophageal cancer	6.95e-05	0.000217	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTT1—esophageal cancer	6.85e-05	0.000214	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOS3—esophageal cancer	6.8e-05	0.000213	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—esophageal cancer	6.78e-05	0.000212	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2A6—esophageal cancer	6.77e-05	0.000212	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.74e-05	0.000211	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—esophageal cancer	6.67e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—esophageal cancer	6.62e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ERBB2—esophageal cancer	6.5e-05	0.000203	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—esophageal cancer	6.48e-05	0.000203	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ENO1—esophageal cancer	6.42e-05	0.000201	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS1—esophageal cancer	6.42e-05	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	6.38e-05	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ERBB2—esophageal cancer	6.36e-05	0.000199	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSME2—esophageal cancer	6.32e-05	0.000198	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSME1—esophageal cancer	6.32e-05	0.000198	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—esophageal cancer	6.11e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—esophageal cancer	5.91e-05	0.000185	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	5.79e-05	0.000181	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCND1—esophageal cancer	5.74e-05	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	5.69e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCND1—esophageal cancer	5.62e-05	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1A—esophageal cancer	5.55e-05	0.000174	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—EP300—esophageal cancer	5.55e-05	0.000174	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.52e-05	0.000173	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP1B1—esophageal cancer	5.46e-05	0.000171	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1A—esophageal cancer	5.44e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	5.44e-05	0.00017	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EP300—esophageal cancer	5.29e-05	0.000165	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOS3—esophageal cancer	5.18e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EP300—esophageal cancer	5.18e-05	0.000162	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP19A1—esophageal cancer	5.13e-05	0.000161	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	4.94e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	4.85e-05	0.000152	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMOX1—esophageal cancer	4.68e-05	0.000147	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—esophageal cancer	4.61e-05	0.000144	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.59e-05	0.000144	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—esophageal cancer	4.51e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—esophageal cancer	4.5e-05	0.000141	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCB1—esophageal cancer	4.49e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—esophageal cancer	4.41e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCND1—esophageal cancer	4.28e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	4.14e-05	0.00013	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—esophageal cancer	4.1e-05	0.000128	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EP300—esophageal cancer	3.94e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—esophageal cancer	3.91e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	3.83e-05	0.00012	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—esophageal cancer	3.78e-05	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—esophageal cancer	3.7e-05	0.000116	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—esophageal cancer	3.44e-05	0.000108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.4e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—esophageal cancer	3.36e-05	0.000105	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CREBBP—esophageal cancer	3e-05	9.4e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	2.92e-05	9.13e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—esophageal cancer	2.82e-05	8.83e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NOS3—esophageal cancer	2.69e-05	8.42e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.46e-05	7.7e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—EP300—esophageal cancer	2.05e-05	6.4e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.51e-05	4.74e-05	CbGpPWpGaD
